Pen Needles Market

Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Global Forecast to 2024

Report Code: MD 2851 Feb, 2019, by marketsandmarkets.com

[143 Pages Report] The pen needles market is expected to reach USD 1.8 billion by 2024 from an estimated USD 1.1 billion in 2019, at a CAGR of 10.8% during the forecast period. Growth in the pen needles market is mainly driven by factors such as the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. The growing preference for biosimilar drugs is another factor providing a wide range of growth opportunities for key players in the market.

Pen Needles Market

The standard pen needles segment held the largest share of the market in 2018

Based on type, the market is segmented into standard and safety pen needles. In 2018, the standard pen needles segment accounted for the largest share of the pen needles market. Growth in this market is associated with the low cost of standard pen needles. The low cost of standard pen needles has also led to their wide adoption in emerging economies such as China, India, and Brazil where the presence of safety pen needles is very low to negligible. However, as standard needles are not equipped with safety shields, the risk of accidental needlestick injuries (NSIs) with the use of these needles is high.

The insulin therapy segment to grow at the highest CAGR during the forecast period

On the basis of therapy, the pen needles market is segmented into insulin, GLP-1, growth hormone, and other therapies such as osteoporosis, fertility, and obesity. The insulin therapy segment is expected to grow at a higher CAGR during the forecast period primarily due to the high and growing diabetic population globally. Since pen needles need to be replaced after every injection, the rising use of insulin pens is a major factor driving the demand for pen needles. Additionally, favorable reimbursement scenario for pen needles in several North American, European, and Asian countries is the other major factor driving the demand for pen needles.

In 2018, the 8mm segment accounted for the largest share of the pen needles market

On the basis of length, the market is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. In 2018, the 8mm segment accounted for the largest share of the pen needles market. Growth in this market is largely driven by the high adoption of these needles among diabetes patients. However, the usage of these needles is likely to witness a decrease in the coming years due to the increased usage of shorter needles that cause less pain and enable easy insulin administration

Pen Needles Market

North America dominated the pen needles market in 2018

North America dominated the pen needles market in 2018. The large share of the North American pen needles market can primarily be attributed growing diabetes prevalence and favorable reimbursement scenario for pen needles, federal initiatives to create awareness about injection techniques, increasing market penetration by leading players, and the development of improved pen needle technologies. For instance, Ypsomed Holding AG (Switzerland) has launched mylife Clickfine DiamondTip pen needles with the innovative 6-bevel technology, and Becton, Dickinson and Company (US) has upgraded its pen needles with the PentaPoint and EasyFlow technology.

Key Market Players

The key players in the pen needles market are Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), and Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan), and Owen Mumford (UK).

Becton, Dickinson and Company (US) is a leading company in the field of drugs delivery systems. The company is a pioneer in the field of pen needles. The company offers a wide range of products including both standard and safety pen needles, such as BD Ultra-Fine Nano, BD PentaPoint products, and BD AutoShield Duo Pen Needles. BD also collaborates with universities, medical centers, and other entities to conduct R&D programs to support its efforts in specialized fields. In order to maintain its position, the company has adopted growth strategies, such as geographical expansions and product launches. The company opened its Advanced Diabetes Care facility in Andover, Massachusetts, US, in 2015.

Novo Nordisk (Denmark) is a leader in the diabetes care market with an experience of more than 90 years in diabetes care. As a significant volume of Novo Nordisk’s insulins are used in injectable devices, the company is witnessing a surge in the sale of its insulin pens and supplies including pen needles. The company has its distribution and production facilities in more than 79 countries and markets its products in more than 180 countries. The growing diabetes market globally serves as an opportunity for the company to gain stable revenues from its diabetes care segment. In this regards, the company provided medical treatment to 26.8 million diabetic patients worldwide, in 2015 and targets to reach 40 million people with its diabetic care products by 2020.

Recent Developments

  • In 2018, Becton, Dickinson and Company (US) launched its BD Ultra-Fine micro pen needle 6mm x 32G in the market.
  • In 2016, Ypsomed (Switzerland) entered into an agreement with Tonghua Dongbao Pharmaceutical (China) with an aim to distribute its mylife Clickfine pen needles in China.
  • In 2015, Ypsomed (Switzerland) launched mylife Clickfine DiamondTip pen needles.

Key Questions addressed by the report

  • Which are the key players in the market and how intense is the competition?
  • What are the growth strategies being implemented by major market players?
  • Emerging countries have immense opportunities for the growth of the pen needles market, will this scenario continue?
  • Which product market will dominate in the pen needles market in the future?
  • What are the challenges hindering the adoption of pen needles?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Market Data Validation and Triangulation
    2.3 Assumptions for the Study

3 Executive Summary (Page No. - 27)

4 Premium Insights (Page No. - 31)
    4.1 Pen Needles Market Overview
    4.2 Europe: Pen Needles Market, By Type & Country, 2018
    4.3 North America: Pen Needles Market, By Type, 2018
    4.4 Pen Needles Market: Geographic Snapshot

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growing Prevalence of Chronic Diseases
                    5.2.1.2 Favorable Reimbursement in Selected Countries
           5.2.2 Restraints
                    5.2.2.1 Preference for Alternative Modes of Drug Delivery
                    5.2.2.2 Poor Reimbursement Scenario in Developing Countries
           5.2.3 Opportunities
                    5.2.3.1 Growing Preference for Biosimilar Drugs
           5.2.4 Challenges
                    5.2.4.1 Reuse of Pen Needles

6 Industry Insights (Page No. - 39)
    6.1 Introduction
    6.2 Porter’s Five Forces Analysis
           6.2.1 Threat of New Entrants
           6.2.2 Bargaining Power of Suppliers
           6.2.3 Bargaining Power of Buyers
           6.2.4 Segment Rivalry
           6.2.5 Threat of Substitutes
    6.3 Competitive Intensity
           6.3.1 Evaluation Parameters
           6.3.2 Scoring Methodology
           6.3.3 Competitive Intensity Score, By Company
                    6.3.3.1 Competitive Intensity Score for BD
                    6.3.3.2 Competitive Intensity Score for Novo Nordisk
                    6.3.3.3 Competitive Intensity Score for Ypsomed
           6.3.4 Competitive Intensity Mapping of BD, Novo Nordisk, and Ypsomed
           6.3.5 Comparison of Evaluation Parameters, By Company
                    6.3.5.1 Pricing
                    6.3.5.2 Product Portfolio
                    6.3.5.3 Product Launches/Technological Advancements
                    6.3.5.4 Geographical Presence
                    6.3.5.5 Promotional/Marketing Activities
                    6.3.5.6 Sponsorships/Donations/Education/Awareness Campaigns
                    6.3.5.7 M&A, Partnerships, Collaborations, Agreements, and Expansions
                    6.3.5.8 Certifications/Accreditations/Awards

7 Pen Needles Market, By Type (Page No. - 56)
    7.1 Introduction
    7.2 Standard Pen Needles
           7.2.1 Standard Pen Needles are Preferred Over Safety Pen Needles as They are More Affordable, Considering the Need for Daily Insulin Intake
    7.3 Safety Pen Needles
           7.3.1 Demand for Safety Pen Needles to Rise Due to Growing Concerns Regarding the Prevention of Nsis Associated With Standard Needles

8 Pen Needles Market, By Length (Page No. - 61)
    8.1 Introduction
    8.2 4mm
           8.2.1 4mm Pen Needles are Expected to Register the Highest Growth Rate During the Forecast Period
    8.3 5mm
           8.3.1 5mm Pen Needles to Register the Second-Highest Growth Rate During the Study Period
    8.4 6mm
           8.4.1 6mm Pen Needles are the Most Commonly Used Needles Across the Globe
    8.5 8mm
           8.5.1 8mm Pen Needles Will Continue to Dominate the Pen Needles Market During the Forecast Period
    8.6 10mm
           8.6.1 Availability of Shorter Pen Needles to Restrain the Growth of the 10mm Pen Needles Market
    8.7 12mm
           8.7.1 Popularity of Shorter & Less Painful Needles to Hamper the Growth of the 12mm Pen Needles Market

9 Pen Needles Market, By Therapy (Page No. - 67)
    9.1 Introduction
    9.2 Insulin Therapy
           9.2.1 Rising Prevalence of Diabetes to Drive the Growth of the Pen Needles Market for Insulin Therapy
    9.3 Glucagon-Like Peptide-1 (GLP-1) Therapy
           9.3.1 Strong Focus of Major Pharmaceutical Companies to Introduce GLP-1 Drugs in the Market to Drive the Growth of the Pen Needles Market for GLP-1 Therapy
    9.4 Growth Hormone Therapy
           9.4.1 Development of Sustained-Release Growth Hormone Formulations for Reducing Injection Frequency to Restrain the Growth of the Pen Needles Market for Growth Hormone Therapy
    9.5 Other Therapies

10 Pen Needles Market, By Mode of Purchase (Page No. - 74)
     10.1 Introduction
     10.2 Retail
             10.2.1 Retail Purchases of Pen Needles to Witness High Growth in the Coming Years Owing to the Growing Popularity of Online Purchases
     10.3 Non-Retail
             10.3.1 The Large Number of Needle-Phobic Diabetic Patients is Supporting the Growth of This Segment

11 Pen Needles Market, By Region (Page No. - 79)
     11.1 Introduction
     11.2 North America
             11.2.1 US
                        11.2.1.1 US Dominates the Pen Needles Market in North America
             11.2.2 Canada
                        11.2.2.1 High Diabetes Prevalence and Growing Geriatric Population Will Support Pen Needle Uptake
     11.3 Europe
             11.3.1 Germany
                        11.3.1.1 High Diabetes Expenditure and Reimbursement for Pen Needles is Expected to Drive the Market in Germany
             11.3.2 UK
                        11.3.2.1 NHS Support and Access to Cost-Effective Pen Needles are Likely to Drive the Market in the UK
             11.3.3 France
                        11.3.3.1 Higher Insurance Coverage and Increase in Aging Population and Affordability Contribute to Demand for Pen Needles
             11.3.4 Italy
                        11.3.4.1 Wide Regional Variations in Terms of Benefits and Coverage to Slow Growth in Italy
             11.3.5 Spain
                        11.3.5.1 Supportive Regulations Mandating the Use of Safety Pen Needles to Boost the Growth of the Spanish Market
             11.3.6 Rest of Europe
     11.4 Asia Pacific
             11.4.1 Japan
                        11.4.1.1 High Diabetes Incidence and Approval of Injectable Insulin to Drive the Pen Needles Market in Japan
             11.4.2 China
                        11.4.2.1 Suboptimal Insurance Coverage Policies Will Dampen Market Growth
             11.4.3 India
                        11.4.3.1 Low Pen Needle Penetration, Lack of Awareness to Restrain Market Growth in India
             11.4.4 Rest of Asia Pacific
     11.5 Rest of the World
             11.5.1 Latin America
                        11.5.1.1 Healthcare Reforms to Drive Growth in Mexico
             11.5.2 Middle East & Africa
                        11.5.2.1 Favorable Reforms in South Africa to Bolster Market Growth

12 Competitive Landscape (Page No. - 110)
     12.1 Overview
     12.2 Market Share (As of 2018)
             12.2.1 Becton, Dickinson and Company
             12.2.2 Novo Nordisk
             12.2.3 Ypsomed
     12.3 Competitive Leadership Mapping (2018)
             12.3.1 Vendor Inclusion Criteria
             12.3.2 Visionary Leaders
             12.3.3 Innovators
             12.3.4 Dynamic Differentiators
             12.3.5 Emerging Companies
     12.4 Competitive Scenario
             12.4.1 Product Launches
             12.4.2 Expansions
             12.4.3 Agreements

13 Company Profiles (Page No. - 116)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     13.1 Becton, Dickinson and Company
     13.2 Novo Nordisk
     13.3 Ypsomed
     13.4 Owen Mumford, Ltd.
     13.5 HTL-Strefa
     13.6 B. Braun Melsungen
     13.7 Terumo Corporation
     13.8 Ultimed
     13.9 Allison Medical, Inc.
     13.10 Artsana S.P.A.
     13.11 Arkray, Inc.
     13.12 Glucorx

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 132)
     14.1 Discussion Guide
     14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.3 Available Customizations
     14.4 Related Reports
     14.5 Author Details


List of Tables (87 Tables)

Table 1 Evaluation Parameters & Scores
Table 2 Competitive Intensity for BD
Table 3 Competitive Intensity for Novo Nordisk
Table 4 Competitive Intensity for Ypsomed
Table 5 Market, By Type, 2017–2024 (USD Million)
Table 6 Market, By Type, 2017–2024 (Million Units)
Table 7 Standard Pen Needles: Market, By Region, 2017–2024 (USD Million)
Table 8 Standard Pen Needles: Market, By Region, 2017–2024 (Million Units)
Table 9 Safety Pen Needles: Market, By Region, 2017–2024 (USD Million)
Table 10 Safety Pen Needles: Market, By Region, 2017–2024 (Thousand Units)
Table 11 Market, By Length, 2017–2024 (USD Million)
Table 12 4mm Pen Needles: Market, By Region, 2017–2024 (USD Million)
Table 13 5mm Pen Needles: Market, By Region, 2017–2024 (USD Million)
Table 14 6mm Pen Needles: Market, By Region, 2017–2024 (USD Million)
Table 15 8mm Pen Needles: Market, By Region, 2017–2024 (USD Million)
Table 16 10mm Pen Needles: Market, By Region, 2017–2024 (USD Million)
Table 17 12mm Pen Needles: Market, By Region, 2017–2024 (USD Million)
Table 18 Market, By Therapy, 2017–2024 (USD Million)
Table 19 Market for Insulin Therapy, By Region, 2017–2024 (USD Million)
Table 20 Market for GLP-1 Therapy, By Region, 2017–2024 (USD Million)
Table 21 Market for Growth Hormone Therapy, By Region, 2017–2024 (USD Million)
Table 22 Market for Other Therapies, By Region, 2017–2024 (USD Million)
Table 23 Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 24 Market for Retail Purchases, By Region, 2017–2024 (USD Million)
Table 25 Indicative List of Regulatory Acts
Table 26 Market for Non-Retail Purchases, By Region, 2017–2024 (USD Million)
Table 27 Market, By Region, 2017-2024 (USD Million)
Table 28 Market, By Region, 2017-2024 (Million Units)
Table 29 North America: Market, By Country, 2017–2024 (USD Million)
Table 30 North America: Market, By Country, 2017–2024 (Million Units)
Table 31 North America: Market, By Type, 2017–2024 (USD Million)
Table 32 North America: Market, By Type, 2017–2024 (Million Units)
Table 33 North America: Market, By Needle Length, 2017–2024 (USD Million)
Table 34 North America: Market, By Therapy, 2017–2024 (USD Million)
Table 35 North America: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 36 US: Market, By Type, 2017–2024 (USD Million)
Table 37 US: Market, By Type, 2017–2024 (Million Units)
Table 38 Canada: Market, By Type, 2017–2024 (USD Million)
Table 39 Canada: Market, By Type, 2017–2024 (Million Units)
Table 40 Europe: Market, By Country, 2017-2024 (USD Million)
Table 41 Europe: Market, By Country, 2017–2024 (Million Units)
Table 42 Europe: Market, By Type, 2017–2024 (USD Million)
Table 43 Europe: Market, By Type, 2017–2024 (Million Units)
Table 44 Europe: Market, By Needle Length, 2017–2024 (USD Million)
Table 45 Europe: Market, By Therapy, 2017–2024 (USD Million)
Table 46 Europe: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 47 Germany: Market, By Type, 2017–2024 (USD Million)
Table 48 Germany: Market, By Type, 2017–2024 (Million Units)
Table 49 UK: Market, By Type, 2017–2024 (USD Million)
Table 50 UK: Market, By Type, 2017–2024 (Million Units)
Table 51 France: Market, By Type, 2017–2024 (USD Million)
Table 52 France: Market, By Type, 2017–2024 (Million Units)
Table 53 Italy: Market, By Type, 2017–2024 (USD Million)
Table 54 Italy: Market, By Type, 2017–2024 (Million Units)
Table 55 Spain: Market, By Type, 2017–2024 (USD Million)
Table 56 Spain: Market, By Type, 2017–2024 (Million Units)
Table 57 RoE: Market, By Type, 2017–2024 (USD Million)
Table 58 RoE: Market, By Type, 2017–2024 (Million Units)
Table 59 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 60 Asia Pacific: Market, By Country, 2017–2024 (Million Units)
Table 61 Asia Pacific: Market, By Type, 2017–2024 (USD Million)
Table 62 Asia Pacific: Market, By Type, 2017–2024 (Million Units)
Table 63 Asia Pacific: Market, By Needle Length, 2017–2024 (USD Million)
Table 64 Asia Pacific: Market, By Therapy, 2017–2024 (USD Million)
Table 65 Asia Pacific: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 66 Japan: Market, By Type, 2017–2024 (USD Million)
Table 67 Japan: Market, By Type, 2017–2024 (Million Units)
Table 68 China: Market, By Type, 2017–2024 (USD Million)
Table 69 China: Market, By Type, 2017–2024 (Million Units)
Table 70 India: Market, By Type, 2017–2024 (USD Million)
Table 71 India: Market, By Type, 2017–2024 (Million Units)
Table 72 RoAPAC: Market, By Type, 2017–2024 (USD Million)
Table 73 RoAPAC: Market, By Type, 2017–2024 (Thousand Units)
Table 74 RoW: Market, By Region, 2017–2024 (USD Million)
Table 75 RoW: Market, By Region, 2017–2024 (Million Units)
Table 76 RoW: Market, By Type, 2017–2024 (USD Million)
Table 77 RoW: Market, By Type, 2017–2024 (Thousand Units)
Table 78 RoW: Market, By Needle Length, 2017–2024 (USD Million)
Table 79 RoW: Market, By Therapy, 2017–2024 (USD Million)
Table 80 RoW: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 81 Latin America: Pen Needles Market, By Type, 2017–2024 (USD Million)
Table 82 Latin America: Pen Needles Market, By Type, 2017–2024 (Thousand Units)
Table 83 Middle East & Africa: Pen Needles Market, By Type, 2017–2024 (USD Million)
Table 84 Middle East & Africa: Pen Needles Market, By Type, 2017–2024 (Thousand Units)
Table 85 Product Launches
Table 86 Expansions
Table 87 Agreements


List of Figures (46 Figures)

Figure 1 Pen Needles Market Segmentation
Figure 2 Pen Needles Market: Research Methodology
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Pen Needles Market, By Type, 2018
Figure 9 Pen Needles Market, By Length, 2018–2024
Figure 10 Pen Needles Market, By Therapy, 2018–2024
Figure 11 Pen Needles Market, By Mode of Purchase, 2018
Figure 12 Geographic Snapshot: Pen Needles Market, 2018
Figure 13 Growing Prevalence of Chronic Diseases to Drive the Growth of the Pen Needles Market
Figure 14 Standard Pen Needles to Dominate the European Pen Needles Market During the Forecast Period
Figure 15 Standard Pen Needles to Dominate the North American Pen Needles Market During the Forecast Period
Figure 16 Asia Pacific is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 17 Pen Needles Market: Drivers, Restraints, Opportunities, & Challenges
Figure 18 Porter’s Five Forces Analysis: Pen Needles Market
Figure 19 Scoring Methodology
Figure 20 Comparisons of Competitive Intensity Scores: BD, Novo Nordisk, and Ypsomed
Figure 21 Relative Positioning of Companies Based on Competitive Intensity Score and Pen Needle Focus
Figure 22 Safety Pen Needles By BD and Standard Pen Needles By Novo Nordisk are Premium-Priced
Figure 23 BD has A Robust Portfolio of Both Standard and Safety Pen Needles
Figure 24 BD has A Higher Focus on Innovation for Its Pen Needles Business
Figure 25 BD and Novo Nordisk have A Strong Geographic Presence
Figure 26 BD and Novo Nordisk Showcase High Focus on Marketing & Promotional Activities
Figure 27 Novo Nordisk has A High Focus on Diabetes Education & Awareness
Figure 28 Novo Nordisk Aggressively Follows the Strategies of Partnerships & Agreements
Figure 29 BD, Novo Nordisk, and Ypsomed Equally Exhibit High Compliance With Industry Standards
Figure 30 Standard Pen Needles to Command the Largest Share of the Pen Needles Market During the Forecast Period
Figure 31 8mm Pen Needles Segment Accounted for the Largest Market Share in 2018
Figure 32 Insulin Therapy Segment to Command the Largest Share of the Pen Needles Market in 2018
Figure 33 Retail Segment Will Continue to Dominate the Pen Needles Market During the Forecast Period
Figure 34 North America Will Continue to Dominate the Global Pen Needles Market During the Forecast Period
Figure 35 North America: Pen Needles Market Snapshot
Figure 36 Europe: Pen Needles Market Snapshot
Figure 37 Asia Pacific: Pen Needles Market Snapshot
Figure 38 Rest of World: Pen Needles Market Snapshot
Figure 39 Pen Needles Market Share (As of 2018)
Figure 40 MnM Dive-Vendor Comparison Matrix: Pen Needles Market
Figure 41 Strategies Adopted By Market Players (2015-2018)
Figure 42 Becton, Dickinson and Company: Company Snapshot
Figure 43 Novo Nordisk: Company Snapshot
Figure 44 Ypsomed: Company Snapshot
Figure 45 B.Braun: Company Snapshot
Figure 46 Terumo: Company Snapshot

The study involved four major activities in estimating the current market size for pen needles. Exhaustive secondary research was done to collect information about the market, peer markets, and the parent market. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Thirdly, both top-down and bottom-up approaches were employed to estimate the complete market size. Finally, the market breakdown and data triangulation method was used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as the WHO, International Diabetes Federation, World Bank, Global Burden of Disease Study, Food and Drug Administration, American Diabetes Association, American Association of Diabetes Educators, Centers for Disease Control and Prevention, Diabetes Canada, Statistics Canada, European Association for the Study of Diabetes, European Society of Endocrinology, Diabetes UK, National Health Service, OECD Health Statistics, Asian Association for the Study of Diabetes, ASEAN Federation of Endocrine Societies, Statistical Handbook of Japan, OECD Obesity Update, Brazilian Diabetes Society, Latin American Diabetes Association, directories, industry journals, databases, press releases, and annual reports of the companies have been used to identify and collect information useful for the study of this market.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the pen needles market. The primary sources from the demand side include personnel from research organizations, academic institutes, and purchase managers. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

Following the breakdown of primary respondents—

Pen Needles Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by type, end user, and region).

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides.

Report Objectives

  • To define, measure, and describe the pen needles market by type, length, therapy, mode of purchase, and region
  • To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW
  • To strategically analyze the market structure and profile key players in the pen needles market and comprehensively analyze their core competencies
  • To track and analyze company developments such as product launches and enhancements; acquisitions; expansions; and agreements, partnerships, & collaborations in the pen needles market

Scope of the report

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Value (USD)

Segments covered

Type, Length, Therapy, Mode of Purchase, and Region

Geographies covered

North America, Europe, Asia Pacific, and Rest of the World

Companies covered

Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan), Artsana S.p.a (Italy), Owen Mumford Ltd. (UK), Allison Medical, Inc. (US), UltiMed, Inc. (US), ARKRAY, Inc. (Japan), and GlucoRx (UK).

This research report categorizes the pen needles market based on type, needle length, therapy, mode of purchase, and region.

Pen needles market, by type:

  • Standard Pen Needles
  • Safety Pen Needles

Pen needles market, by length:

  • 4mm
  • 5mm
  • 6mm
  • 8mm
  • 10mm
  • 12mm

Pen needles market, by therapy:

  • Insulin
  • GLP-1
  • Growth Hormone Therapy
  • Other Therapies (osteoporosis, infertility, obesity, cardiovascular disease, rheumatoid arthritis, and Crohn’s disease)

Pen needles market, by mode of purchase:

  • Retail
  • Non-retail

Pen needles market, by region:

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • India
    • Japan
    • ROAPAC
  • Rest of the World
    • Latin America
    • Middle East & Africa

Available customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • A further breakdown of the Rest of Asia Pacific CRT market into South Korea, New Zealand, and other South East Asian countries
  • A further breakdown of the European CRT market into Belgium, Netherlands, and Rest of Europe.

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Company Information

  • Detailed analysis and profiling of additional market players
Report Code
MD 2851
Published ON
Feb, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Pen Needles Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home